Market Size of Superdisintegrants Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 8.10 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Superdisintegrants Market Analysis
The superdisintegrants market studied was expected to grow with a CAGR of approximately 8.1% over the forecast period. The major factors accrediting to the growth of the market are increasing adoption of orally disintegrating tablets, and increasing healthcare expenditure and awareness. Furthermore, the increasing number of pediatric patients and the geriatric population cannot swallow solid forms of medication. These agents are used as a viscosity-improving agent in drug-loaded films, having improved performance, and maintains high drug content uniformity. Superdisintegrants are added to solid dosage forms such as capsules or tablets that aids them to disintegrate when submerged in liquid. Due to this benefit, these are significantly used in the manufacturing of disintegrating oral formulations, which further increases the demand for superdisintegrants in the market. However, the concerns related to safety and quality are the major drawback of market growth.
Superdisintegrants Industry Segmentation
As per the scope of the report, superdisintegrant is a kind of excipient that is used for the tablet-based drug delivery in the pharmaceutical industry. This report is segmented by Product Type, by Formulation, by Therapeutic Area, and by Geography.
| By Product Type | |||||||
| Natural Superdisintegrants | |||||||
| |||||||
| Others |
| By Formulation | |
| Tablets | |
| Capsules |
| By Therapeutic Area | |
| Neurological Diseases | |
| Gastrointestinal Diseases | |
| Oncology | |
| Others |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| Rest of World |
Superdisintegrants Market Size Summary
The superdisintegrants market is poised for significant growth, driven by the increasing adoption of orally disintegrating tablets and heightened healthcare expenditure and awareness. These agents play a crucial role in enhancing the performance of drug-loaded films by improving viscosity and maintaining high drug content uniformity. They are essential in the manufacturing of disintegrating oral formulations, which are particularly beneficial for pediatric and geriatric populations who have difficulty swallowing solid medication forms. Despite their advantages, concerns regarding safety and quality pose challenges to market expansion. The market is also witnessing a shift towards natural superdisintegrants, which offer benefits such as biodegradability and non-toxicity, further propelling segment growth.
North America is anticipated to lead the superdisintegrants market, supported by a robust healthcare infrastructure, presence of key industry players, and substantial research and development funding. The region's growth is bolstered by favorable government initiatives and an increase in research partnerships. The United States, in particular, holds a significant market share due to its supportive healthcare policies and developed healthcare market. The competitive landscape of the superdisintegrants market features major players like BASF SE, Ashland Global Holdings Inc., and DuPont, among others. These companies are actively expanding their capabilities and optimizing supply chains to meet the global demand for high-quality pharmaceutical excipients.
Superdisintegrants Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Adoption of Orally Disintegrating Tablets
-
1.2.2 Increase Healthcare Expenditure and Awareness
-
1.2.3 Rising Prevalence Of Chronic Conditions With Increasing Number Of Pediatric And Geriatric Population
-
-
1.3 Market Restraints
-
1.3.1 Concerns About the Safety and Quality of Product
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Product Type
-
2.1.1 Natural Superdisintegrants
-
2.1.2 Synthetic Superdisintegrants
-
2.1.2.1 Modified Starch
-
2.1.2.2 Modified Cellulose
-
2.1.2.3 Crospovidone
-
2.1.2.4 Calcium Silicates
-
2.1.2.5 Ion Exchange Resins
-
-
2.1.3 Others
-
-
2.2 By Formulation
-
2.2.1 Tablets
-
2.2.2 Capsules
-
-
2.3 By Therapeutic Area
-
2.3.1 Neurological Diseases
-
2.3.2 Gastrointestinal Diseases
-
2.3.3 Oncology
-
2.3.4 Others
-
-
2.4 Geography
-
2.4.1 North America
-
2.4.1.1 United States
-
2.4.1.2 Canada
-
2.4.1.3 Mexico
-
-
2.4.2 Europe
-
2.4.2.1 Germany
-
2.4.2.2 United Kingdom
-
2.4.2.3 France
-
2.4.2.4 Italy
-
2.4.2.5 Spain
-
2.4.2.6 Rest of Europe
-
-
2.4.3 Asia-Pacific
-
2.4.3.1 China
-
2.4.3.2 Japan
-
2.4.3.3 India
-
2.4.3.4 Australia
-
2.4.3.5 South Korea
-
2.4.3.6 Rest of Asia-Pacific
-
-
2.4.4 Rest of World
-
-
Superdisintegrants Market Size FAQs
What is the current Superdisintegrants Market size?
The Superdisintegrants Market is projected to register a CAGR of 8.10% during the forecast period (2024-2029)
Who are the key players in Superdisintegrants Market?
BASF SE, Ashland Global Holdings Inc., DuPont, Roquette Freres and DFE Pharma are the major companies operating in the Superdisintegrants Market.
